European Markets for Vascular Access Devices 2008 (15 Countries)

Product Code IDR00084
Publication Date September 2008
Publisher iData Research
Product Type Report
Pages 681
ISBN Number not applicable
Change currency
PDF £7,270.00 €8,755 $11,496 BUY >
PRINT £6,955 €8,375 $10,998 BUY >
ONLINE SUBSCRIPTION £ € $ BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

European Markets for Vascular Access Devices 2008 (15 Countries)

Vascular access devices primarily consist of disposable devices. They range from devices that can be high volume and low cost (peripheral intravenous catheters (PIVCs)), to devices that are relatively low volume and high cost (implantable ports). PIVCs represent the market segment with the largest value, due to the sheer amount of units sold. Growth in the market will be driven by the increasing penetration of new technologies, such as safety products, products to reduce infection, and products with an added clinical benefit. In addition, the increasing and aging population will drive unit growth

Contents

  • LIST OF FIGURESV
  • LIST OF CHARTS
  • EXECUTIVE SUMMARY
    • 1.1 OVEREW
    • 1.2 TREND ANALYSIS BY COUNTRY
    • 1.3 COUNTRY PROFILE, GERMANY
    • 1.4 IMPLANTABLE PORTS & HUBER NEEDLES
    • 1.5 CENTRAL VENOUS CATHETERS (CVCS)
    • 1.6 DIALYSIS CATHETERS
    • 1.7 PERIPHERALLY INSERTED CENTRAL CATHETERS (PICCS)
    • 1.8 PERIPHERAL INTRAVENOUS CATHETERS (PIVCS)
    • 1.9 COMPETITIVE ANALYSIS
  • RESEARCH METHODOLOGY
    • 2.1 RESEARCH SCOPE
    • 2.2 IDATA'S 9-STEP METHODOLOGY
    • 2.2.1 Step 1: Project Initiation & Team Selection
    • 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
    • 2.2.3 Step 3: Preparation for Interews & Survey Design
    • 2.2.4 Step 4: Performing Primary Research
    • 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
    • 2.2.6 Step 6: Market Forecasting
    • 2.2.7 Step 7: Identify Strategic Opportunities
    • 2.2.8 Step 8: Final Reew and Market Release
    • 2.2.9 Step 9: Customer Feedback and Market Monitoring
  • INTRODUCTION TO VASCULAR ACCESS DECES
    • 3.1 IMPLANTABLE PORTS & HUBER NEEDLES
    • 3.1.1 Implantable Port Patients
    • 3.1.2 Port Implantation Procedures
    • 3.1.3 Port Infusion
    • 3.1.4 Port Maintenance
    • 3.1.5 Port Material
    • 3.1.6 Lumen Number
    • 3.1.7 Power Injectable Ports
    • 3.1.8 Safety Huber Needles
    • 3.2 CENTRAL VENOUS CATHETERS (CVCS)
    • 3.2.1 CVC Procedures
    • 3.2.2 CVC Kits
    • 3.2.3 CVC Market Segments
    • 3.2.4 Anti-Microbial CVCs
    • 3.2.5 Chronic CVCs
    • 3.2.6 Lumen Number
    • 3.3 DIALYSIS CATHETERS
    • 3.3.1 Dialysis Catheters
    • 3.3.2 Peritoneal Dialysis
    • 3.3.3 AV Fistulae
    • 3.3.4 AV Grafts
    • 3.4 PICCS
    • 3.4.1 PICC Placement
    • 3.4.2 Catheter Material
    • 3.4.3 Lumen Number
    • 3.4.4 Power Injectable PICCs
    • 3.5 PERIPHERAL INTRAVENOUS CATHETERS (PIVCS)
    • 3.5.1 PIVC Placement
    • 3.5.2 Safety PIVCs
    • 3.5.3 Ported and Straight PIVCs
  • EUROPEAN MARKET FOR VASCULAR ACCESS DECES
    • 4.1 MARKET OVEREW
    • 4.1.1 Vascular Access Dece Market Analysis and Forecast
    • 4.1.2 Competite Analysis
    • 4.2 IMPLANTABLE PORTS
    • 4.2.1 Huber Needles
    • 4.2.2 Implantable Ports Market Drers
    • 4.2.3 Huber Needle Specific Market Drers
    • 4.2.4 Implantable Port Market Limiters
    • 4.2.5 Competite Analysis
    • 4.3 CENTRAL VENOUS CATHETERS
    • 4.3.1 Combined CVC Market
    • 4.3.2 Total Acute Central Venous Catheters
    • 4.3.3 Acute Antimicrobial CVC Market
    • 4.3.4 Total Chronic CVC Market
    • 4.3.5 Market Drers
    • 4.3.6 Market Limiters
    • 4.3.7 Competite Analysis
    • 4.4 DIALYSIS CATHETERS
    • 4.4.1 Combined Haemodialysis Catheter Market
    • 4.4.2 Acute Haemodialysis Catheter Market
    • 4.4.3 Chronic Haemodialysis Catheter Market
    • 4.4.4 Market Drers
    • 4.4.5 Market Limiters
    • 4.4.6 Competite Analysis
    • 4.5 PICCS
    • 4.5.1 Power Injectable PICCs
    • 4.5.2 Market Drers
    • 4.5.3 Market Limiters
    • 4.5.4 Competite Analysis
    • 4.6 PERIPHERAL INTRAVENOUS CATHETERS (PIVCS)
    • 4.6.1 Total Peripheral Intravenous Catheter Market
    • 4.6.2 Safety Peripheral Intravenous Catheter Market
    • 4.6.3 Market Drers
    • 4.6.4 Market Limiters
    • 4.6.5 Competite Analysis
    • 4.7 MERGERS AND ACQUISITIONS
    • 4.7.1 Churchill Medical Systems Purchased by Vygon
    • 4.7.2 Arrow International Purchased by Teleflex Medical
    • 4.7.3 Boston Scientific Fluid Management and Venous Access Businesses
    • Purchased by Asta Capital Partners
  • COUNTRY PROFILES
    • 5.1 INTRODUCTION
    • 5.1.1 Population
    • 5.1.2 GDP Per Capita
    • 5.1.3 Implantable Ports Used Per 10,000 Inhabitants
    • 5.1.4 Price Index
    • 5.2 GERMANY
    • 5.3 FRANCE
    • 5.4 U.K
    • 5.5 ITALY
    • 5.6 SPAIN
    • 5.7 BENELUX
    • 5.8 SCANDINAA
    • 5.9 PORTUGAL
    • 5.10 AUSTRIA
    • 5.11 SWITZERLAND
  • GERMAN MARKET FOR VASCULAR ACCESS DECES
    • 6.1 INTRODUCTION
    • 6.2 IMPLANTABLE PORT MARKET ANALYSIS AND FORECAST
    • 6.2.1 Implantable Ports
    • 6.2.2 Huber Needles
    • 6.2.3 Market Drers
    • 6.2.4 Huber Needle Specific Market Drers
    • 6.2.5 Market Limiters
    • 6.2.6 Competite Analysis
    • 6.3 CENTRAL VENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 6.3.1 Acute Central Venous Catheters
    • 6.3.2 Acute Anti-Microbial Central Venous Catheters
    • 6.3.3 Chronic Central Venous Catheters
    • 6.3.4 Market Drers
    • 6.3.5 Market Limiters
    • 6.3.6 Competite Analysis
    • 6.4 DIALYSIS CATHETER MARKET ANALYSIS AND FORECAST
    • 6.4.1 Acute Haemodialysis Catheters
    • 6.4.2 Chronic Haemodialysis Catheters
    • 6.4.3 Market Drers
    • 6.4.4 Market Limiters
    • 6.4.5 Competite Analysis
    • 6.5 PICC MARKET ANALYSIS AND FORECAST
    • 6.5.1 Market Drers
    • 6.5.2 Market Limiters
    • 6.6 PERIPHERAL INTRAVENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 6.6.1 Total Peripheral IV Catheters
    • 6.6.2 Safety Peripheral IV Catheters
    • 6.6.3 Market Drers
    • 6.6.4 Market Limiters
    • 6.6.5 Competite Analysis
  • FRENCH MARKET FOR VASCULAR ACCESS DECES
    • 7.1 INTRODUCTION
    • 7.2 IMPLANTABLE PORT MARKET ANALYSIS AND FORECAST
    • 7.2.1 Implantable Ports
    • 7.2.2 Huber Needles
    • 7.2.3 Market Drers
    • 7.2.4 Huber Needle Specific Market Drers
    • 7.2.5 Market Limiters
    • 7.2.6 Competite Analysis
    • 7.3 CENTRAL VENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 7.3.1 Acute Central Venous Catheters
    • 7.3.2 Acute Anti-Microbial Central Venous Catheters
    • 7.3.3 Chronic Central Venous Catheters
    • 7.3.4 Market Drers
    • 7.3.5 Market Limiters
    • 7.3.6 Competite Analysis
    • 7.4 DIALYSIS CATHETER MARKET ANALYSIS AND FORECAST
    • 7.4.1 Acute Haemodialysis Catheters
    • 7.4.2 Chronic Haemodialysis Catheters
    • 7.4.3 Market Drers
    • 7.4.4 Market Limiters
    • 7.4.5 Competite Analysis
    • 7.5 PICC MARKET ANALYSIS AND FORECAST
    • 7.5.1 Market Drers
    • 7.5.2 Market Limiters
    • 7.5.3 Competite Analysis
    • 7.6 PERIPHERAL INTRAVENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 7.6.1 Total Peripheral IV Catheters
    • 7.6.2 Safety Peripheral IV Catheters
    • 7.6.3 Market Drers
    • 7.6.4 Market Limiters
    • 7.6.5 Competite Analysis
    • U.K. MARKET FOR VASCULAR ACCESS DECES
    • 8.1 INTRODUCTION
    • 8.2 IMPLANTABLE PORT MARKET ANALYSIS AND FORECAST
    • 8.2.1 Implantable Ports
    • 8.2.2 Huber Needles
    • 8.2.3 Market Drers
    • 8.2.4 Huber Needle Specific Market Drers
    • 8.2.5 Market Limiters
    • 8.2.6 Competite Analysis
    • 8.3 CENTRAL VENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 8.3.1 Acute Central Venous Catheters
    • 8.3.2 Acute Anti-Microbial Central Venous Catheters
    • 8.3.3 Chronic Central Venous Catheters
    • 8.3.4 Market Drers
    • 8.3.5 Market Limiters
    • 8.3.6 Competite Analysis
    • 8.4 DIALYSIS CATHETER MARKET ANALYSIS AND FORECAST
    • 8.4.1 Acute Haemodialysis Catheters
    • 8.4.2 Chronic Haemodialysis Catheters
    • 8.4.3 Market Drers
    • 8.4.4 Market Limiters
    • 8.4.5 Competite Analysis
    • 8.5 PICC MARKET ANALYSIS AND FORECAST
    • 8.5.1 Market Drers
    • 8.5.2 Market Limiters
    • 8.5.3 Competite Analysis
    • 8.6 PERIPHERAL INTRAVENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 8.6.1 Total Peripheral IV Catheters
    • 8.6.2 Safety Peripheral IV Catheters
    • 8.6.3 Market Drers
    • 8.6.4 Market Limiters
    • 8.6.5 Competite Analysis
  • ITALIAN MARKET FOR VASCULAR ACCESS DECES
    • 9.1 INTRODUCTION
    • 9.2 IMPLANTABLE PORT MARKET ANALYSIS AND FORECAST
    • 9.2.1 Implantable Ports
    • 9.2.2 Huber Needles
    • 9.2.3 Market Drers
    • 9.2.4 Huber Needle Specific Market Drers
    • 9.2.5 Market Limiters
    • 9.2.6 Competite Analysis
    • 9.3 CENTRAL VENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 9.3.1 Acute Central Venous Catheters
    • 9.3.2 Acute Anti-Microbial Central Venous Catheters
    • 9.3.3 Chronic Central Venous Catheters
    • 9.3.4 Market Drers
    • 9.3.5 Market Limiters
    • 9.3.6 Competite Analysis
    • 9.4 DIALYSIS CATHETER MARKET ANALYSIS AND FORECAST
    • 9.4.1 Acute Haemodialysis Catheters
    • 9.4.2 Chronic Haemodialysis Catheters
    • 9.4.3 Market Drers
    • 9.4.4 Market Limiters
    • 9.4.5 Competite Analysis
    • 9.5 PICC MARKET ANALYSIS AND FORECAST
    • 9.5.1 Market Drers
    • 9.5.2 Market Limiters
    • 9.5.3 Competite Analysis
    • 9.6 PERIPHERAL INTRAVENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 9.6.1 Total Peripheral IV Catheters
    • 9.6.2 Safety Peripheral IV Catheters
    • 9.6.3 Market Drers
    • 9.6.4 Market Limiters
    • 9.6.5 Competite Analysis
  • SPANISH MARKET FOR VASCULAR ACCESS DECES
    • 10.1 INTRODUCTION
    • 10.2 IMPLANTABLE PORT MARKET ANALYSIS AND FORECAST
    • 10.2.1 Implantable Ports
    • 10.2.2 Huber Needles
    • 10.2.3 Market Drers
    • 10.2.4 Huber Needle Specific Market Drers
    • 10.2.5 Market Limiters
    • 10.2.6 Competite Analysis
    • 10.3 CENTRAL VENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 10.3.1 Acute Central Venous Catheters
    • 10.3.2 Acute Anti-Microbial Central Venous Catheters
    • 10.3.3 Chronic Central Venous Catheters
    • 10.3.4 Market Drers
    • 10.3.5 Market Limiters
    • 10.3.6 Competite Analysis
    • 10.4 DIALYSIS CATHETER MARKET ANALYSIS AND FORECAST
    • 10.4.1 Acute Haemodialysis Catheters
    • 10.4.2 Chronic Haemodialysis Catheters
    • 10.4.3 Market Drers
    • 10.4.4 Market Limiters
    • 10.4.5 Competite Analysis
    • 10.5 PICC MARKET ANALYSIS AND FORECAST
    • 10.5.1 Market Drers
    • 10.5.2 Market Limiters
    • 10.5.3 Competite Analysis
    • 10.6 PERIPHERAL INTRAVENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 10.6.1 Total Peripheral IV Catheters
    • 10.6.2 Safety Peripheral IV Catheters
    • 10.6.3 Market Drers
    • 10.6.4 Market Limiters
    • 10.6.5 Competite Analysis
  • BENELUAN MARKET FOR VASCULAR ACCESS DECES
    • 11.1 INTRODUCTION
    • 11.2 IMPLANTABLE PORT MARKET ANALYSIS AND FORECAST
    • 11.2.1 Implantable Ports
    • 11.2.2 Huber Needles
    • 11.2.3 Market Drers
    • 11.2.4 Huber Needle Specific Market Drers
    • 11.2.5 Market Limiters
    • 11.2.6 Competite Analysis
    • 11.3 CENTRAL VENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 11.3.1 Acute Central Venous Catheters
    • 11.3.2 Acute Anti-Microbial Central Venous Catheters
    • 11.3.3 Chronic Central Venous Catheters
    • 11.3.4 Market Drers
    • 11.3.5 Market Limiters
    • 11.3.6 Competite Analysis
    • 11.4 DIALYSIS CATHETER MARKET ANALYSIS AND FORECAST
    • 11.4.1 Acute Haemodialysis Catheters
    • 11.4.2 Chronic Haemodialysis Catheters
    • 11.4.3 Market Drers
    • 11.4.4 Market Limiters
    • 11.4.5 Competite Analysis
    • 11.5 PICC MARKET ANALYSIS AND FORECAST
    • 11.5.1 Market Drers
    • 11.5.2 Market Limiters
    • 11.5.3 Competite Analysis
    • 11.6 PERIPHERAL INTRAVENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 11.6.1 Total Peripheral IV Catheters
    • 11.6.2 Safety Peripheral IV Catheters
    • 11.6.3 Market Drers
    • 11.6.4 Market Limiters
    • 11.6.5 Competite Analysis
  • SCANDINAAN MARKET FOR VASCULAR ACCESS DECES
    • 12.1 INTRODUCTION
    • 12.2 IMPLANTABLE PORT MARKET ANALYSIS AND FORECAST
    • 12.2.1 Implantable Ports
    • 12.2.2 Huber Needles
    • 12.2.3 Market Drers
    • 12.2.4 Huber Needle Specific Market Drers
    • 12.2.5 Market Limiters
    • 12.2.6 Competite Analysis
    • 12.3 CENTRAL VENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 12.3.1 Acute Central Venous Catheters
    • 12.3.2 Acute Anti-Microbial Central Venous Catheters
    • 12.3.3 Chronic Central Venous Catheters
    • 12.3.4 Market Drers
    • 12.3.5 Market Limiters
    • 12.3.6 Competite Analysis
    • 12.4 DIALYSIS CATHETER MARKET ANALYSIS AND FORECAST
    • 12.4.1 Acute Haemodialysis Catheters
    • 12.4.2 Chronic Haemodialysis Catheters
    • 12.4.3 Market Drers
    • 12.4.4 Market Limiters
    • 12.4.5 Competite Analysis
    • 12.5 PICC MARKET ANALYSIS AND FORECAST
    • 12.5.1 Market Drers
    • 12.5.2 Market Limiters
    • 12.5.3 Competite Analysis
    • 12.6 PERIPHERAL INTRAVENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 12.6.1 Total Peripheral IV Catheters
    • 12.6.2 Safety Peripheral IV Catheters
    • 12.6.3 Market Drers
    • 12.6.4 Market Limiters
    • 12.6.5 Competite Analysis
  • PORTUGUESE MARKET FOR VASCULAR ACCESS DECES
    • 13.1 INTRODUCTION
    • 13.2 IMPLANTABLE PORT MARKET ANALYSIS AND FORECAST
    • 13.2.1 Implantable Ports
    • 13.2.2 Huber Needles
    • 13.2.3 Market Drers
    • 13.2.4 Huber Needle Specific Market Drers
    • 13.2.5 Market Limiters
    • 13.2.6 Competite Analysis
    • 13.3 CENTRAL VENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 13.3.1 Acute Central Venous Catheters
    • 13.3.2 Acute Anti-Microbial Central Venous Catheters
    • 13.3.3 Chronic Central Venous Catheters
    • 13.3.4 Market Drers
    • 13.3.5 Market Limiters
    • 13.3.6 Competite Analysis
    • 13.4 DIALYSIS CATHETER MARKET ANALYSIS AND FORECAST
    • 13.4.1 Acute Haemodialysis Catheters
    • 13.4.2 Chronic Haemodialysis Catheters
    • 13.4.3 Market Drers
    • 13.4.4 Market Limiters
    • 13.4.5 Competite Analysis
    • 13.5 PICC MARKET
    • 13.6 PERIPHERAL INTRAVENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 13.6.1 Total Peripheral IV Catheters
    • 13.6.2 Safety Peripheral IV Catheters
    • 13.6.3 Market Drers
    • 13.6.4 Market Limiters
    • 13.6.5 Competite Analysis
  • AUSTRIAN MARKET FOR VASCULAR ACCESS DECES
    • 14.1 INTRODUCTION
    • 14.2 IMPLANTABLE PORT MARKET ANALYSIS AND FORECAST
    • 14.2.1 Implantable Ports
    • 14.2.2 Huber Needles
    • 14.2.3 Market Drers
    • 14.2.4 Huber Needle Specific Market Drers
    • 14.2.5 Market Limiters
    • 14.2.6 Competite Analysis
    • 14.3 CENTRAL VENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 14.3.1 Acute Central Venous Catheters
    • 14.3.2 Acute Anti-Microbial Central Venous Catheters
    • 14.3.3 Chronic Central Venous Catheters
    • 14.3.4 Market Drers
    • 14.3.5 Market Limiters
    • 14.3.6 Competite Analysis
    • 14.4 DIALYSIS CATHETER MARKET ANALYSIS AND FORECAST
    • 14.4.1 Acute Haemodialysis Catheters
    • 14.4.2 Chronic Haemodialysis Catheters
    • 14.4.3 Market Drers
    • 14.4.4 Market Limiters
    • 14.4.5 Competite Analysis
    • 14.5 PICC MARKET
    • 14.6 PERIPHERAL INTRAVENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 14.6.1 Total Peripheral IV Catheters
    • 14.6.2 Safety Peripheral IV Catheters
    • 14.6.3 Market Drers
    • 14.6.4 Market Limiters
    • 14.6.5 Competite Analysis
  • SWISS MARKET FOR VASCULAR ACCESS DECES
    • 15.1 INTRODUCTION
    • 15.2 IMPLANTABLE PORT MARKET ANALYSIS AND FORECAST
    • 15.2.1 Implantable Ports
    • 15.2.2 Huber Needles
    • 15.2.3 Market Drers
    • 15.2.4 Huber Needle Specific Market Drers
    • 15.2.5 Market Limiters
    • 15.2.6 Competite Analysis
    • 15.3 CENTRAL VENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 15.3.1 Acute Central Venous Catheters
    • 15.3.2 Acute Anti-Microbial Central Venous Catheters
    • 15.3.3 Chronic Central Venous Catheters
    • 15.3.4 Market Drers
    • 15.3.5 Market Limiters
    • 15.3.6 Competite Analysis
    • 15.4 DIALYSIS CATHETER MARKET ANALYSIS AND FORECAST
    • 15.4.1 Acute Haemodialysis Catheters
    • 15.4.2 Chronic Haemodialysis Catheters
    • 15.4.3 Market Drers
    • 15.4.4 Market Limiters
    • 15.4.5 Competite Analysis
    • 15.5 PICC MARKET
    • 15.6 PERIPHERAL INTRAVENOUS CATHETER MARKET ANALYSIS AND FORECAST
    • 15.6.1 Total Peripheral IV Catheters
    • 15.6.2 Safety Peripheral IV Catheters
    • 15.6.3 Market Drers
    • 15.6.4 Market Limiters
    • 15.6.5 Competite Analysis
  • ABBREATIONS
  • LIST OF FIGURES
  • EXECUTIVE SUMMARY
  • RESEARCH METHODOLOGY
  • INTRODUCTION TO VASCULAR ACCESS DECES
  • EUROPEAN MARKET FOR VASCULAR ACCESS DECES
    • Figure 4-1: Total European Vascular Access Dece Market, 2004 2014 ()
    • Figure 4-2: Vascular Access Dece Market Value by Dece, 2007 and 2014
    • Figure 4-3: Leading Competitors in the Vascular Access Dece Market, Europe, 2007
    • Figure 4-4: Total European Implantable Port Market, 2004 2014 ()
    • Figure 4-5: Total European Implantable Port Market, 2004 2014 (US$)
    • Figure 4-6: Total European Huber Needle Market, 2004 2014 ()
    • Figure 4-7: Total European Huber Needle Market, 2004 2014 (US$)
    • Figure 4-8: Drers and Limiters for the Implantable Port Market, 2007
    • Figure 4-9: Leading Competitors in the Implantable Port Market, Europe, 2007
    • Figure 4-10: Combined European CVC Market, 2004 2014 ()
    • Figure 4-11: Combined European CVC Market, 2004 2014 (US$)
    • Figure 4-12: Total European Acute CVC Market, 2004 2014 ()
    • Figure 4-13: Total European Acute CVC Market, 2004 2014 (US$)
    • Figure 4-14: European Acute Antimicrobial CVC Market, 2004 2014 ()
    • Figure 4-15: European Acute Antimicrobial CVC Market, 2004 2014 (US$)
    • Figure 4-16: Total European Chronic CVC Market, 2004 2014 ()
    • Figure 4-17: Total European Chronic CVC Market, 2004 2014 (US$)
    • Figure 4-18: Drers and Limiters for the European CVC Market, 2007
    • Figure 4-19: Leading Competitors in the Acute CVC Market, Europe, 2007
    • Figure 4-20: Leading Competitors in the Chronic CVC Market, Europe, 2007
    • Figure 4-21: Combined European Dialysis Catheter Market, 2004 2014 ()
    • Figure 4-22: Combined European Dialysis Catheter Market, 2004 2014 (US$)
    • Figure 4-23: European Acute Dialysis Catheter Market, 2004 2014 ()
    • Figure 4-24: European Acute Dialysis Catheter Market, 2004 2014 (US$)
    • Figure 4-25: European Chronic Dialysis Catheter Market, 2004 2014 ()
    • Figure 4-26: European Chronic Dialysis Catheter Market, 2004 2014 (US$)
    • Figure 4-27: Drers and Limiters for the European Dialysis Catheter Market,2007
    • Figure 4-28: Leading Competitors in the Acute Dialysis Catheter Market, Europe, 2007
    • Figure 4-29: Leading Competitors in the Chronic Dialysis Catheter Market, Europe, 2007
    • Figure 4-30: Total European PICC Market, 2004 2014 ()
    • Figure 4-31: Total European PICC Market, 2004 2014 (US$)
    • Figure 4-32: Drers and Limiters for the PICC Market, 2007
    • Figure 4-33: Leading Competitors in the PICC Market, Europe, 2007
    • Figure 4-34: Total European PIVC Market, 2004 2014 ()
    • Figure 4-35: Total European PIVC Market, 2004 2014 (US$)
    • Figure 4-36: European Safety PIVC Market, 2004 2014 ()
    • Figure 4-37: European Safety PIVC Market, 2004 2014 (US$)
    • Figure 4-38: European Drers and Limiters for the PIVC Market, 2007
    • Figure 4-39: Leading Competitors in the PIVC Market, Europe, 2007
  • COUNTRY PROFILES
  • GERMAN MARKET FOR VASCULAR ACCESS DECES
    • Figure 6-1: Total German Market for Implantable Ports, 2004 2014 ()
    • Figure 6-2: Total German Market for Implantable Ports, 2004 2014 (US$)
    • Figure 6-3: German Market for Huber Needles, 2004 2014 ()
    • Figure 6-4: German Market for Huber Needles, 2004 2014 (US$)
    • Figure 6-5: Drers and Limiters for the Implantable Port Market, 2007
    • Figure 6-6: Leading Competitors in the Implantable Port Market, Germany,2007
    • Figure 6-7: German Market for Acute CVCs, 2004 2014 ()
    • Figure 6-8: German Market for Acute CVCs, 2004 2014 (US$)
    • Figure 6-9: German Market for Acute Anti-Microbial CVCs, 2004 2014 ()
    • Figure 6-10: German Market for Acute Anti-Microbial CVCs, 2004 2014(US$)
    • Figure 6-11: German Market for Chronic CVCs, 2004 2014 ()
    • Figure 6-12: German Market for Chronic CVCs, 2004 2014 (US$)
    • Figure 6-13: Drers and Limiters for the German CVC Market, 2007
    • Figure 6-14: Leading Competitors in the CVC Market, Germany, 2007
    • Figure 6-15: German Market for Acute Dialysis Catheters, 2004 2014 ()
    • Figure 6-16: German Market for Acute Dialysis Catheters, 2004 2014 (US$)
    • Figure 6-17: German Market for Chronic Dialysis Catheters, 2004 2014 ()
    • Figure 6-18: German Market for Chronic Dialysis Catheters, 2004 2014(US$)
    • Figure 6-19: Drers and Limiters for the Dialysis Catheter Market, Germany,2007
    • Figure 6-20: Leading Competitors in the Dialysis Catheter Market, Germany,2007
    • Figure 6-21: Total German Market for Peripherally Inserted Central Catheters,2004 2014 ()
    • Figure 6-22: Total German Market for Peripherally Inserted Central Catheters,2004 2014 (US$)
    • Figure 6-23: Drers and Limiters for the PICC Market, 2007
    • Figure 6-24: Total German Market for PIVCs, 2004 2014 ()
    • Figure 6-25: Total German Market for PIVCs, 2004 2014 (US$)
    • Figure 6-26: Total German Market for Safety PIVCs, 2004 2014 ()
    • Figure 6-27: Total German Market for Safety PIVCs, 2004 2014 (US$)
    • Figure 6-28: German Drers and Limiters for the PIVC Market, 2007
    • Figure 6-29: Leading Competitors in the PIVC Market, Germany, 2007
  • FRENCH MARKET FOR VASCULAR ACCESS DECES
    • Figure 7-1: Total French Market for Implantable Ports, 2004 2014 ()
    • Figure 7-2: Total French Market for Implantable Ports, 2004 2014 (US$)
    • Figure 7-3: French Market for Huber Needles, 2004 2014 ()
    • Figure 7-4: French Market for Huber Needles, 2004 2014 (US$)
    • Figure 7-5: Drers and Limiters for the Implantable Port Market, 2007
    • Figure 7-6: Leading Competitors in the Implantable Port Market, France, 2007
    • Figure 7-7: French Market for Acute CVCs, 2004 2014 ()
    • Figure 7-8: French Market for Acute CVCs, 2004 2014 (US$)
    • Figure 7-9: French Market for Acute Anti-Microbial CVCs, 2004 2014 ()
    • Figure 7-10: French Market for Acute Anti-Microbial CVCs, 2004 2014(US$)
    • Figure 7-11: French Market for Chronic CVCs, 2004 2014 ()
    • Figure 7-12: French Market for Chronic CVCs, 2004 2014 (US$)
    • Figure 7-13: Drers and Limiters for the French CVC Market, 2007
    • Figure 7-14: Leading Competitors in the CVC Market, France, 2007
    • Figure 7-15: French Market for Acute Dialysis Catheters, 2004 2014 ()
    • Figure 7-16: French Market for Acute Dialysis Catheters, 2004 2014 (US$)
    • Figure 7-17: French Market for Chronic Dialysis Catheters, 2004 2014 ()
    • Figure 7-18: French Market for Chronic Dialysis Catheters, 2004 2014 (US$)
    • Figure 7-19: Drers and Limiters for the Dialysis Catheter Market, France,2007
    • Figure 7-20: Leading Competitors in the Dialysis Catheter Market, France,2007
    • Figure 7-21: Total French Market for Peripherally Inserted Central Catheters,2004 2014 ()
    • Figure 7-22: Total French Market for Peripherally Inserted Central Catheters,2004 2014 (US$)
    • Figure 7-23: Drers and Limiters for the PICC Market, 2007
    • Figure 7-24: Leading Competitors in the PICC Market, France, 2007
    • Figure 7-25: Total French Market for PIVCs, 2004 2014 ()
    • Figure 7-26: Total French Market for PIVCs, 2004 2014 (US$)
    • Figure 7-27: Total French Market for Safety PIVCs, 2004 2014 ()
    • Figure 7-28: Total French Market for Safety PIVCs, 2004 2014 (US$)
    • Figure 7-29: French Drers and Limiters for the PIVC Market, 2007
    • Figure 7-30: Leading Competitors in the PIVC Market, France, 2007
    • U.K. MARKET FOR VASCULAR ACCESS DECES
    • Figure 8-1: Total U.K. Market for Implantable Ports, 2004 2014 ()
    • Figure 8-2: Total U.K. Market for Implantable Ports, 2004 2014 (US$)
    • Figure 8-3: U.K. Market for Implantable Ports, 2004 2014 ()
    • Figure 8-4: U.K. Market for Huber Needles, 2004 2014 ()
    • Figure 8-5: U.K. Market for Huber Needles, 2004 2014 (US$)
    • Figure 8-6: U.K. Market for Huber Needles, 2004 2014 ()
    • Figure 8-7: Drers and Limiters for the Implantable Port Market, U.K., 2007
    • Figure 8-8: Leading Competitors in the Implantable Port Market, U.K., 2007
    • Figure 8-9: U.K. Market for Acute CVCs, 2004 2014 ()
    • Figure 8-10: U.K. Market for Acute CVCs, 2004 2014 (US$)
    • Figure 8-11: U.K. Market for Acute CVCs, 2004 2014 ()
    • Figure 8-12: U.K. Market for Acute Anti-Microbial CVCs, 2004 2014 ()
    • Figure 8-13: U.K. Market for Acute Anti-Microbial CVCs, 2004 2014 (US$)
    • Figure 8-14: U.K. Market for Acute Anti-Microbial CVCs, 2004 2014 ()
    • Figure 8-15: U.K. Market for Chronic CVCs, 2004 2014 ()
    • Figure 8-16: U.K. Market for Chronic CVCs, 2004 2014 (US$)
    • Figure 8-17: U.K. Market for Chronic CVCs, 2004 2014 ()
    • Figure 8-18: Drers and Limiters for the U.K. CVC Market, 2007
    • Figure 8-19: Leading Competitors in the CVC Market, U.K., 2007
    • Figure 8-20: U.K. Market for Acute Dialysis Catheters, 2004 2014 ()
    • Figure 8-21: U.K. Market for Acute Dialysis Catheters, 2004 2014 (US$)
    • Figure 8-22: U.K. Market for Acute Dialysis Catheters, 2004 2014 ()
    • Figure 8-23: U.K. Market for Chronic Dialysis Catheters, 2004 2014 ()
    • Figure 8-24: U.K. Market for Chronic Dialysis Catheters, 2004 2014 (US$)
    • Figure 8-25: U.K. Market for Chronic Dialysis Catheters, 2004 2014 ()
    • Figure 8-26: Drers and Limiters for the Dialysis Catheter Market, U.K.,2007
    • Figure 8-27: Leading Competitors in the Dialysis Catheter Market, U.K., 2007
    • Figure 8-28: Total U.K. Market for Peripherally Inserted Central Catheters,2004 2014 ()
    • Figure 8-29: Total U.K. Market for Peripherally Inserted Central Catheters,2004 2014 (US$)
    • Figure 8-30: Total U.K. Market for Peripherally Inserted Central Catheters,2004 2014 ()
    • Figure 8-31: Drers and Limiters for the PICC Market, 2007
    • Figure 8-32: Leading Competitors in the PICC Market, U.K., 2007
    • Figure 8-33: Total U.K. Market for PIVCs, 2004 2014 ()
    • Figure 8-34: Total U.K. Market for PIVCs, 2004 2014 (US$)
    • Figure 8-35: Total U.K. Market for PIVCs, 2004 2014 ()
    • Figure 8-36: Total U.K. Market for Safety PIVCs, 2004 2014 ()
    • Figure 8-37: Total U.K. Market for Safety PIVCs, 2004 2014 (US$)
    • Figure 8-38: Total U.K. Market for Safety PIVCs, 2004 2014 ()
    • Figure 8-39: U.K. Drers and Limiters for the PIVC Market, 2007
    • Figure 8-40: Leading Competitors in the PIVC Market, U.K., 2007
  • ITALIAN MARKET FOR VASCULAR ACCESS DECES
    • Figure 9-1: Total Italian Market for Implantable Ports, 2004 2014 ()
    • Figure 9-2: Total Italian Market for Implantable Ports, 2004 2014 (US$)
    • Figure 9-3: Italian Market for Huber Needles, 2004 2014 ()
    • Figure 9-4: Italian Market for Huber Needles, 2004 2014 (US$)
    • Figure 9-5: Drers and Limiters for the Implantable Port Market, 2007
    • Figure 9-6: Leading Competitors in the Implantable Port Market, Italy, 2007
    • Figure 9-7: Italian Market for Acute CVCs, 2004 2014 (